Gateshead, United Kingdom

Jamie Marshall


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
2 patents (USPTO):

Title: Innovator Spotlight: Jamie Marshall from Gateshead

Introduction

Jamie Marshall is a talented inventor based in Gateshead, GB. With a strong background in pharmaceutical innovations, Jamie has made significant contributions to the field of medicine, particularly through the development of plasma kallikrein inhibitors. His work is marked by a commitment to advancing therapeutic solutions.

Latest Patents

Jamie holds two patents, which are focused on the crystalline forms of plasma kallikrein inhibitors. His latest patents disclose pure crystalline forms of 1-benzyl-N-(4-carbamimidoylbenzyl)-1H-pyrazole-4-carboxamide acetate, along with an amorphous form, pharmaceutical compositions thereof, and methods for making the same. These innovations highlight Jamie's dedication to improving drug formulation and delivery systems.

Career Highlights

Throughout his career, Jamie has been associated with prominent companies in the pharmaceutical industry, including Rezolute, Inc. and Activesite Pharmaceuticals, Inc. His experiences at these organizations have bolstered his expertise in drug development and patent formulation, fostering a progressive approach to pharmaceutical research.

Collaborations

In his professional journey, Jamie has worked alongside notable collaborators such as Sukanto Sinha and Tamie Chilcote. These partnerships have enhanced the creative and innovative processes within their projects, leading to advancements in their respective fields.

Conclusion

As an inventor, Jamie Marshall demonstrates the importance of innovation in the pharmaceutical industry. His contributions, particularly in developing new forms of plasma kallikrein inhibitors, mark a significant step forward in therapeutic advancements. Jamie's career exemplifies the impact of collaboration and expertise in driving successful inventions, ultimately benefiting the healthcare sector.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…